[FG] Daikeler Thomas

Blanchard-Rohner, Geraldine et al. (2024) ‘COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children’, Pediatric Infectious Disease Journal, 43(4), pp. 361–364. Available at: https://doi.org/10.1097/inf.0000000000004206.

Andre, Maya C. et al. (2024) ‘Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial’, eClinicalMedicine, 67. Available at: https://doi.org/10.1016/j.eclinm.2023.102358.

Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44. Available at: https://doi.org/10.1007/s10875-024-01667-z.

Köhn, P. et al. (2024) ‘Supra-aortal intima-media thickness in treatment-naïve polymyalgia patients compared to matched controls’, Clinical Rheumatology [Preprint]. Available at: https://doi.org/10.1007/s10067-024-07021-3.

Welzel, Tatjana et al. (2024) ‘Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases’, Pediatric Rheumatology, 22. Available at: https://doi.org/10.1186/s12969-023-00930-8.

Welzel, Tatjana, Woerner, Andreas and Kaiser, Daniela (2024) ‘Update systemische juvenile idiopathische Arthritis’, Paediatrica, 35(1), pp. 20–24.

Bellutti Enders F et al. (2023) ‘Alpha-gal syndrome initially misdiagnosed as chronic spontaneous urticaria in a pediatric patient: a case report and review of the literature’, Journal of Medical Case Reports, 17(1). Available at: https://doi.org/10.1186/s13256-022-03718-8.

Ankli B and Daikeler T (2023) ‘[Update Gout].’, Therapeutische Umschau. Revue therapeutique, 80(1), pp. 17–26. Available at: https://doi.org/10.1024/0040-5930/a001402.

Dejaco, Christian et al. (2023) ‘The provisional OMERACT ultrasonography score for giant cell arteritis’, Annals of the Rheumatic Diseases, 82, pp. 556–564. Available at: https://doi.org/10.1136/ard-2022-223367.

Donners, Ricardo et al. (2023) ‘Chronic stage magnetic resonance imaging findings in patients with shoulder injury related to vaccine administration (SIRVA)’, Skeletal Radiology, 52, pp. 1695–1701. Available at: https://doi.org/10.1007/s00256-023-04334-3.

Hemmig, Andrea K. et al. (2023) ‘A diagnostic performance study of the 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis in a cohort of patients presenting with suspected giant cell arteritis’, Arthritis and Rheumatology, 75, pp. 1075–1077. Available at: https://doi.org/10.1002/art.42440.

Hemmig, Andrea Katharina et al. (2023) ‘Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study’, RMD open, 9. Available at: https://doi.org/10.1136/rmdopen-2022-002866.

Hemmig, Andrea K. et al. (2023) ‘Magnetic Resonance Imaging Findings Corresponding to Vasculitis as Defined via [¹⁸F]FDG Positron Emission Tomography or Ultrasound’, Diagnostics, 13. Available at: https://doi.org/10.3390/diagnostics13233559.

Hirsiger, Julia R. et al. (2023) ‘Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1087502.

Iudici, Michele et al. (2023) ‘Management of giant-cell arteritis in Switzerland: an online national survey’, Swiss Medical Weekly, 153. Available at: https://doi.org/10.57187/smw.2023.40051.

Locher, Cosima et al. (2023) ‘Chronic pain concepts of pediatricians: a qualitative survey’, Pain Reports, 8, p. E1060. Available at: https://doi.org/10.1097/pr9.0000000000001060.

Mensch, Noemi et al. (2023) ‘Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study’, RMD Open, 9. Available at: https://doi.org/10.1136/rmdopen-2023-003301.

Roth, Johannes and Wörner, Andreas (2023) ‘Juvenile idiopathische Arthritis’, Leading Opinions Orthopädie und Rheumatologie, (4), pp. 22–24.

Welzel, Tatjana, Aeschlimann, Florence and Wörner, Andreas (2023) ‘Autoinflammatorische Erkrankungen’, Rheuma Schweiz, (3), pp. 62–68.

Welzel, Tatjana et al. (2023) ‘Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial’, The Lancet Child and Adolescent Health, 7, pp. 238–248. Available at: https://doi.org/10.1016/s2352-4642(23)00020-2.

Woerner, Andreas and Berben, Lut (2023) ‘Transitionskonzepte: Ziele und Grenzen’, in Weber, Peter; (ed.) Transition bei neurologischen Erkrankungen. Springer (Transition bei neurologischen Erkrankungen).

Woerner, Andreas and Berben, Lut (2023) ‘Transition: Perspektiven und Bedarfsanalyse’, in Weber, Peter; (ed.) Transition bei neurologischen Erkrankungen. Springer (Transition bei neurologischen Erkrankungen).

Monfort J.B. et al. (2022) ‘Cutaneous manifestations of monogenic auto-inflammatory diseases: An international cohort study from the Juvenile Inflammatory Rheumatism cohort’, Journal of the American Academy of Dermatology, 87(6), pp. 1391–1394. Available at: https://doi.org/10.1016/j.jaad.2022.08.015.

Harder N et al. (2022) ‘Chronic Recurrent Multifocal Osteomyelitis in a Child’s Hand: Case Report and Review.’, The journal of hand surgery Asian-Pacific volume, 27(4), pp. 751–754. Available at: https://doi.org/10.1142/s2424835522720407.

Hemmig AK et al. (2022) ‘Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.’, Seminars in arthritis and rheumatism, 55, p. 152017. Available at: https://doi.org/10.1016/j.semarthrit.2022.152017.

Capoferri G et al. (2022) ‘Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis.’, Clinics in dermatology, 40(4), pp. 397–401. Available at: https://doi.org/10.1016/j.clindermatol.2022.02.013.

Schmitt C et al. (2022) ‘Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.’, Arthritis research & therapy, 24(1), p. 133. Available at: https://doi.org/10.1186/s13075-022-02815-9.

Stegert M, Neumann T and Daikeler T (2022) ‘[ANCA-Associated Vasculitides].’, Therapeutische Umschau. Revue therapeutique, 79(5), pp. 229–237. Available at: https://doi.org/10.1024/0040-5930/a001355.

Zimmermann P et al. (2022) ‘Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study’, Swiss Medical Weekly, 152(21-22). Available at: https://doi.org/10.4414/smw.2022.w30185.

Imfeld S et al. (2022) ‘A Simplified PET/CT Measurement Routine with Excellent Diagnostic Accuracy for the Diagnosis of Giant Cell Arteritis.’, Diagnostics (Basel, Switzerland), 12(3). Available at: https://doi.org/10.3390/diagnostics12030728.

Uka A et al. (2022) ‘Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study’, European Journal of Pediatrics, 181(3), pp. 1245–1255. Available at: https://doi.org/10.1007/s00431-021-04276-9.

Uka A et al. (2022) ‘Correction to: Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study (European Journal of Pediatrics, (2022), 181, 3, (1245-1255), 10.1007/s00431-021-04276-9)’, European Journal of Pediatrics, 181(3), p. 1257. Available at: https://doi.org/10.1007/s00431-021-04359-7.

Du Fay De Lavallaz, Jeanne et al. (2022) ‘Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T’, Circulation, 145, pp. 1764–1779. Available at: https://doi.org/10.1161/circulationaha.121.058489.

Koechlin, Helen et al. (2022) ‘Estimating the prevalence of paediatric chronic pain in Switzerland: an online survey among paediatricians’, Swiss Medical Weekly, 152. Available at: https://doi.org/10.4414/smw.2022.w30194.

Welzel T et al. (2022) ‘Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland.’, Frontiers in pediatrics, 10, p. 993811. Available at: https://doi.org/10.3389/fped.2022.993811.

Dumaine C. et al. (2021) ‘Infectious adverse events in children with juvenile idiopathic arthritis treated with biological agents in a real-life setting: Data from the JIR cohort Évènements indésirables infectieux chez des enfants atteints d’arthrite juvénile idiopathique et traités en vie réelle par biothérapies: données issues de la JIR cohorte’, Revue du Rhumatisme (Edition Francaise), 88(6), pp. 443–449. Available at: https://doi.org/10.1016/j.rhum.2021.02.019.

Berben L et al. (2021) ‘Current practice of transitional care for adolescents and young adults in Swiss paediatric and adult rheumatology centres.’, Swiss medical weekly, 151, p. w30046. Available at: https://doi.org/10.4414/smw.2021.w30046.

Hirsiger, Julia R. et al. (2021) ‘Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination’, Journal of Autoimmunity, 124. Available at: https://doi.org/10.1016/j.jaut.2021.102714.

Welzel T et al. (2021) ‘Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials.’, 19(1). Available at: https://doi.org/10.1186/s12969-021-00593-3.

Prader S. et al. (2021) ‘X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children—A Case Report’. Frontiers Media S.A., 9. Available at: https://doi.org/10.3389/fped.2021.691024.

Sava M et al. (2021) ‘Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study’, Swiss Medical Weekly, 151(31), p. w20550. Available at: https://doi.org/10.4414/smw.2021.20550.

Rollet-Cohen V et al. (2021) ‘Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort’, Clinical Rheumatology, 40(7), pp. 2855–2864. Available at: https://doi.org/10.1007/s10067-020-05553-y.

Rottenburger, Christof et al. (2021) ‘18F-FDG PET/CT compared with ultrasound and biopsy for detection of vasculitis of the temporal artery branches’, Swiss Medical Weekly, 151(23-24). Available at: https://doi.org/10.4414/smw.2021.20512.

Schlapbach LJ et al. (2021) ‘Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland’, Frontiers in Pediatrics, 9, p. 667507. Available at: https://doi.org/10.3389/fped.2021.667507.

Welzel T et al. (2021) ‘Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials.’, Pediatric rheumatology online journal, 19(1), p. 46. Available at: https://doi.org/10.1186/s12969-021-00514-4.

Henes J et al. (2021) ‘Autologous stem cell transplantation for progressive systemic sclerosis: A prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party’, Haematologica, 106(2), pp. 375–383. Available at: https://doi.org/10.3324/haematol.2019.230128.

Baenziger-Sieber P et al. (2021) ‘Throat swelling following tocilizumab infusion-not always angioedema.’, Rheumatology advances in practice, 5(3), p. rkab072. Available at: https://doi.org/10.1093/rap/rkab072.

Hostettler KE et al. (2021) ‘Case Report: Opposite Effects of BRAF Inhibition on Closely Related Clonal Myeloid Disorders.’, 11. Available at: https://doi.org/10.3389/fonc.2021.779523.

Légeret C et al. (2021) ‘JAK Inhibition in a Patient with X-Linked Reticulate Pigmentary Disorder’, 41(1). Available at: https://doi.org/10.1007/s10875-020-00867-7.

Vinit C et al. (2021) ‘Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.’, Frontiers in immunology, 12, p. 744780. Available at: https://doi.org/10.3389/fimmu.2021.744780.

Ogal M et al. (2020) ‘[Pediatric chronic pain : interprofessional and integrative care].’, Revue medicale suisse, 16(716), pp. 2306–2309.

Welzel T, Wörner A and Heininger U (2020) ‘[Travel vaccinations in rheumatic diseases : Specific considerations in children and adults].’, Zeitschrift fur Rheumatologie, 79(9), pp. 865–872. Available at: https://doi.org/10.1007/s00393-020-00852-w.

Aeschlimann FA et al. (2020) ‘Serious adverse events in children with juvenile idiopathic arthritis and other rheumatic diseases on tocilizumab – a real-world experience’, Seminars in Arthritis and Rheumatism, 50(4), pp. 744–748. Available at: https://doi.org/10.1016/j.semarthrit.2020.05.013.

Berger CT and Daikeler T (2020) ‘Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: € Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone” by Samson and Bonnotte’, Annals of the Rheumatic Diseases, 79(8), p. e103. Available at: https://doi.org/10.1136/annrheumdis-2019-215729.

Daly ML et al. (2020) ‘COVID-19 driven care changes in high risk patients from an outpatient to a community setting - A cross-sectional study.’, Pflege, 33(4), pp. 219–227. Available at: https://doi.org/10.1024/1012-5302/a000753.

Alexander T et al. (2020) ‘Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry’, 55(7). Available at: https://doi.org/10.1038/s41409-019-0763-2.

Imfeld S et al. (2020) ‘FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: Congruent or complementary imaging methods?’, Rheumatology (United Kingdom), 59(4), pp. 772–778. Available at: https://doi.org/10.1093/rheumatology/kez362.

Fisher B.A. et al. (2020) ‘Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren’s syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study’, The Lancet Rheumatology, 2(3), pp. e142–e152. Available at: https://doi.org/10.1016/s2665-9913(19)30135-3.

Sharrack B. et al. (2020) ‘Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)’, Bone Marrow Transplantation, 55(2), pp. 283–306. Available at: https://doi.org/10.1038/s41409-019-0684-0.

Cabrera N. et al. (2020) ‘Safety of biological agents in pediatric rheumatic diseases: A real-life multicenter retrospective study using the JIR cohort database Sécurité des agents biologiques dans les maladies rhumatismales pédiatriques : étude rétrospective multicentrique en situation réelle dans la base de données JIRcohorte’, Revue du Rhumatisme (Edition Francaise), 87(1), pp. 43–50. Available at: https://doi.org/10.1016/j.rhum.2019.11.014.

Deigendesch, Nikolaus et al. (2020) ‘Tumoural soft tissue calcification in Down syndrome: association with heterozygous germline SAMD9 mutation and hyperactive type I interferon signaling’, Rheumatology, 59(11), pp. e102–e104. Available at: https://doi.org/10.1093/rheumatology/keaa301.

Dumaine C et al. (2020) ‘Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte’, Joint Bone Spine, 87(1), pp. 49–55. Available at: https://doi.org/10.1016/j.jbspin.2019.07.011.

Fuchs, Philipp S. et al. (2020) ‘Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients’, Frontiers in Immunology, 11(11), p. 613130. Available at: https://doi.org/10.3389/fimmu.2020.613130.

Bischof A et al. (2019) ‘Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study’, Neurology(R) neuroimmunology & neuroinflammation, 6(6). Available at: https://doi.org/10.1212/NXI.0000000000000615.

Hirsiger JR et al. (2019) ‘Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor Activation’, Open Forum Infectious Diseases, 6(9), p. ofz317. Available at: https://doi.org/10.1093/ofid/ofz317.

Ankli B et al. (2019) ‘The target uric acid level in multimorbid patients with gout is difficult to achieve: Data from a longitudinal Swiss single-centre cohort’, Swiss Medical Weekly, 149(35-36), p. w20121. Available at: https://doi.org/10.4414/smw.2019.20121.

Voss P et al. (2019) ‘Poststreptococcal Glomerulonephritis with Unusual Lung Involvement’, Journal of Clinical Rheumatology, 25(6), pp. E87–E89. Available at: https://doi.org/10.1097/rhu.0000000000000734.

Bratu VA et al. (2019) ‘Do Patients With Skin Psoriasis Show Subclinical Axial Inflammation on Magnetic Resonance Imaging of the Sacroiliac Joints and Entire Spine?’, Arthritis Care and Research, 71(8), pp. 1109–1118. Available at: https://doi.org/10.1002/acr.23767.

Berger CT et al. (2019) ‘Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses’, 78(7). Available at: https://doi.org/10.1136/annrheumdis-2018-214704.

Aschwanden M et al. (2019) ‘Vessel wall plasticity in large vessel giant cell arteritis: An ultrasound follow-up study’, Rheumatology (United Kingdom), 58(5), pp. 792–797. Available at: https://doi.org/10.1093/rheumatology/key383.

Cabrera N et al. (2019) ‘Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database’, Joint Bone Spine, 86(3), pp. 343–350. Available at: https://doi.org/10.1016/j.jbspin.2018.08.003.

Schneider T et al. (2019) ‘Characteristics of children and adolescents at the Switzerland-wide first ambulatory interdisciplinary pain clinic at the University Children’s Hospital Basel - a retrospective study’, Swiss medical weekly, 149, p. w20073. Available at: https://doi.org/10.4414/smw.2019.20073.

Panozzo, Catherine A. et al. (2019) ‘Arthritis and arthralgia as an adverse event following immunization: A systematic literature review’, Vaccine, 37(2), pp. 372–383. Available at: https://doi.org/10.1016/j.vaccine.2018.06.067.

Woerner, Andreas et al. (2019) ‘Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data’, Vaccine, 37(2), pp. 384–391. Available at: https://doi.org/10.1016/j.vaccine.2017.08.087.

Ankli, B. et al. (2019) ‘An atypical presentation of Whipple’s disease’, Revue du Rhumatisme (Edition Francaise), 86, pp. 314–315. Available at: https://doi.org/10.1016/j.rhum.2019.03.012.

Aschwanden, M. et al. (2019) ‘Ultrasound in giant cell arteritis’, Gefasschirurgie, 24, pp. 68–74. Available at: https://doi.org/10.1007/s00772-018-0400-1.

Ankli B et al. (2018) ‘Whipple’s disease mimicking an auto-inflammatory disease with myositis and soft tissue inflammation.’, 85(5). Available at: https://doi.org/10.1016/j.jbspin.2018.01.003.

Kipfer B et al. (2018) ‘Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.’, Seminars in hematology. 28.05.2018, 55(4), pp. 242–247. Available at: https://doi.org/10.1053/j.seminhematol.2018.05.002.

Berger CT et al. (2018) ‘The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.’, Swiss medical weekly, 148, p. w14661. Available at: https://doi.org/10.4414/smw.2018.14661.

Ankli B et al. (2018) ‘Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive gout.’, Scandinavian journal of rheumatology. 16.08.2017, 47(2), pp. 127–130. Available at: https://doi.org/10.1080/03009742.2017.1332239.

Schulert GS et al. (2018) ‘Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.’, Arthritis care & research, 70(3), pp. 409–419. Available at: https://doi.org/10.1002/acr.23277.

Bigler MB et al. (2018) ‘Varicella zoster virus-specific T cell responses in untreated giant cell arteritis: comment on the article by England et al.’, 70(2). Available at: https://doi.org/10.1002/art.40363.

Berger, Christoph T., Recher, Mike and Daikeler, Thomas (2018) ‘Interleukin-6 flags infection in tocilizumab-treated giant cell arteritis’, Rheumatology (Oxford, England), 57(1), pp. 196–197. Available at: https://doi.org/10.1093/rheumatology/kex336.

Burkard T et al. (2018) ‘The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.’, PloS one, 13(10), p. e0202105. Available at: https://doi.org/10.1371/journal.pone.0202105.

Kofler T et al. (2018) ‘‘Exercise induced asthma’ is not always asthma.’, 24. Available at: https://doi.org/10.1016/j.rmcr.2018.05.015.

Aydin S.Z. et al. (2017) ‘Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise’, Journal of Rheumatology, 44(12), pp. 1928–1932. Available at: https://doi.org/10.3899/jrheum.161269.

Daikeler T and Tyndall A (2017) ‘Primary angiitis of the central nervous system-a territory about to be discovered.’, Rheumatology (Oxford, England), 56(12), p. 2258. Available at: https://doi.org/10.1093/rheumatology/kex408.

Tampakis, Athanasios et al. (2017) ‘Intrathoracic tumor of the chest wall: A case of Castleman’s disease mimicking myositis of the lower extremities’, GENERAL THORACIC AND CARDIOVASCULAR SURGERY. WOS.SCI, 65, pp. 664–666. Available at: https://doi.org/10.1007/s11748-016-0743-z.

Daikeler, Thomas and Tyndall, Alan (2017) ‘Primary angiitis of the central nervous system-a territory about to be discovered’. OXFORD UNIV PRESS, 56. Available at: https://doi.org/10.1093/rheumatology/kex161.

Dikkes, Alexander et al. (2017) ‘Takayasu arteritis: active or not, that’s the question.’, 56(10). Available at: https://doi.org/10.1093/rheumatology/kex213.

Fisher, Benjamin et al. (2017) ‘The Novel Anti-CD40 Monoclonal Antibody CFZ533 Shows Beneficial Effects in Patients with Primary Sjogren’s Syndrome: A Phase IIa Double-Blind, PlaceboControlled Randomized Trial’. WILEY, 69.

Bischof, A. et al. (2017) ‘PREVALENCE AND CHARACTERISTICS OF NEUROPATHY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIDES: DATA FROM THE DCVAS STUDY’. BMJ PUBLISHING GROUP, 76. Available at: https://doi.org/10.1136/annrheumdis-2017-eular.4151.

Kipfer, B. et al. (2017) ‘SYSTEMIC INFLAMMATORY AND AUTOIMMUNE MANIFESTATIONS IN THE BERNESE MYELODYSPLASTIC SYNDROMES COHORT AND THEIR INFLUENCE ON OUTCOMES’. PERGAMON-ELSEVIER SCIENCE LTD, 55.

Woerner A et al. (2017) ‘IgA vasculitis (Henoch-Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data.’, Vaccine. 26.12.2016, 35(11), pp. 1559–1566. Available at: https://doi.org/10.1016/j.vaccine.2016.09.024.

Bischof, Antje et al. (2017) ‘Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy’, Annals of the rheumatic diseases, 77(7), pp. 1093–1094. Available at: https://doi.org/10.1136/annrheumdis-2017-212045.

Carmona, F. David et al. (2017) ‘A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis’, American journal of human genetics, 100(1), pp. 64–74. Available at: https://doi.org/10.1016/j.ajhg.2016.11.013.

Elkuch, M. et al. (2017) ‘Low immunoglobulin E flags two distinct types of immune dysregulation’, Clinical & Experimental Immunology, 187(3), pp. 345–352. Available at: https://doi.org/10.1111/cei.12885.

Imfeld, Stefan et al. (2017) ‘[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic’, Eur Heart J Cardiovasc Imaging, 19(8), pp. 933–940. Available at: https://doi.org/10.1093/ehjci/jex259.

Kistner, Anne et al. (2017) ‘Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis’, Rheumatology, 56(5), pp. 829–834. Available at: https://doi.org/10.1093/rheumatology/kew469.

Kowal-Bielecka, Otylia et al. (2017) ‘Update of EULAR recommendations for the treatment of systemic sclerosis’, Annals of the Rheumatic Diseases, 76(8), pp. 1327–1339. Available at: https://doi.org/10.1136/annrheumdis-2016-209909.